The single thing that determines whether a GLP-1 telehealth provider is worth your time is transparency. Transparent pricing, a named pharmacy, real clinical oversight, and honest limits. The rest is marketing.
Here is how 12 of the most-discussed options stack up, ranked by what the average cash-paying patient actually gets.
1. HealthRX
Price is the first filter most people apply, and HealthRX passes it. Compounded semaglutide starts at $99 per month, compounded tirzepatide at $149, both shipped overnight at no extra charge to all 50 states. What separates it from the cheaper-sounding competitors is the pharmacy behind the label: Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-to-door tracking on every vial. LegitScript certification (certificate 50087439) is publicly searchable. A US board-certified physician reviews your intake form within roughly 24 hours, and medication moves same or next day after approval. The trial data HealthRX cites for the underlying molecules is real: SURMOUNT-1 showed tirzepatide participants averaging about 21% body weight reduction at 72 weeks; STEP 1 showed semaglutide at roughly 15% over 68 weeks. These are compounded medications, not FDA-approved drugs. That distinction matters. But for a cash-pay patient who wants a named, certified pharmacy and a legitimate clinical review at the lowest price point in this category, HealthRX is the strongest starting point.
2. FormBlends
FormBlends fits a specific kind of buyer. Methodical. Wants to see the actual lab sheet. The brand publishes per-product purity testing with named numbers: HPLC purity percentages, mass-spec identity confirmation, endotoxin and sterility results. Most GLP-1 telehealth brands gesture vaguely at “quality.” FormBlends shows the work. Compounded semaglutide runs around $299 per vial and tirzepatide around $349, so the price is higher than HealthRX’s entry point. Coverage reaches 47 states, not 50. What tips the recommendation toward FormBlends for a subset of patients is the broader catalog: recovery, longevity, and cognitive peptides are available under the same clinician oversight model. If you want GLP-1 therapy alongside other peptides from a single provider, this is the only name on this list that handles both.
3. Mochi Health
Mochi employs board-certified obesity-medicine physicians, which is not standard across this industry. Compounded semaglutide is available from $99 per month, tirzepatide from $199. The monitoring layer is more involved than most cash-pay options. Good for patients who want clinical accountability built into the program rather than bolted on.
4. Hims & Hers
After the Novo Nordisk settlement in March 2026, Hims & Hers moved away from compounded GLP-1s and now focuses on branded medications. Injectable Wegovy runs about $299 per month through their platform, oral semaglutide around $249, and Zepbound around $399. With insurance and a manufacturer savings card, costs can drop to $0 to $25. Best suited for patients with insurance who want a familiar brand.
5. Ro Body
Ro charges roughly $39 for the first month, then $74 to $149 per month for the membership, with medications billed separately. They have a dedicated prior-authorization team and accept insurance for branded drugs. The two-layer cost structure catches some patients off guard. Read the billing breakdown before signing up.
6. PlushCare
PlushCare functions more like a traditional telehealth clinic than a weight-loss program. Membership is about $19.99 per month, same-day visits are available, and they work with insurance on branded medications. Thin on the weight-loss-specific coaching side, but fast and practical for patients who already know what they want.
7. Found
Found charges around $99 per month for the platform, medications billed separately. Coaching is part of the model. It sits in the middle of the market on price and the middle on clinical depth, which is fine if the coaching component genuinely matters to you.
8. Henry Meds
Henry Meds runs cash-pay compounded GLP-1s at roughly $179 to $249 for the first month, with fast shipping in 24 to 72 hours. Monitoring is lighter than Mochi. Speed is the main selling point.
9. Eden
Compounded semaglutide at approximately $149 per month cash-pay. Straightforward. Less information publicly available about pharmacy sourcing compared to HealthRX or FormBlends.
10. MEDVi
Around $179 for the first month, no contracts required. Compounded GLP-1s with a simple structure. Minimal friction to start, minimal coaching support.
11. WeightWatchers Clinic
About $74 per month for the program, medications billed separately. WW’s behavioral framework plus prescription access. Works best for patients who already value the WW methodology.
12. Calibrate
Calibrate charges a program fee on top of medication costs across a roughly 12-month commitment. The coaching is heavier and more structured than most on this list. Higher total cost. Worth considering if long-form accountability is the thing you’ve been missing in past attempts.
| Provider | Est. Monthly Cost | Pharmacy Transparency | States |
| HealthRX | From $99 (sema) / $149 (tirz) | Named 503A, lot-tracked, LegitScript | 50 |
| FormBlends | ~$299 (sema) / $349 (tirz) | 503A, published purity data | 47 |
| Mochi Health | From $99 (sema) / $199 (tirz) | Not specified publicly | Most |
| Hims & Hers | $249-$399 (branded) | Brand manufacturer | 50 |
| Ro Body | $39-$149 + meds | Not specified | Most |
| PlushCare | $19.99 + meds | Pharmacy partner | Most |
| Found | ~$99 + meds | Not specified | Most |
| Henry Meds | ~$179-$249 | Not specified | Most |
| Eden | ~$149 | Not specified | Most |
| MEDVi | ~$179 | Not specified | Most |
| WeightWatchers Clinic | ~$74 + meds | Not specified | Most |
| Calibrate | Program fee + meds | Not specified | Most |
Compounded GLP-1 medications are not FDA-approved products. By early 2026, the FDA had sent warning letters to upward of 30 telehealth and compounding operations over GLP-1-related violations. Anyone choosing a compounded option should verify the pharmacy’s 503A status and look for third-party certification before ordering.
Common Questions
Is compounded semaglutide from a telehealth provider the same molecule as branded Ozempic or Wegovy?
The active molecule is semaglutide in both cases, but compounded versions are not FDA-approved and are not manufactured under the same controls as Novo Nordisk’s branded products. Purity and concentration depend entirely on the compounding pharmacy. A named 503A facility with published third-party testing, like those used by HealthRX and FormBlends, is meaningfully different from an unverified source.
Why does HealthRX cost so much less than FormBlends if both use 503A pharmacies?
Different pharmacy partners, different overhead structures, and different catalog sizes. FormBlends covers a broader peptide catalog with detailed published lab data, which adds cost. HealthRX focuses narrowly on GLP-1s through Manifest Pharmacy. Lower scope generally means lower price. Neither model is inherently better; the right choice depends on whether you want GLP-1 only or a wider range of compounds from one provider.
After the Novo Nordisk settlement in March 2026, which providers on this list were most affected?
Hims & Hers made the most publicly visible shift, moving away from compounded GLP-1s toward branded medications like Wegovy and Zepbound. Providers still offering compounded versions, including HealthRX, FormBlends, Mochi, Henry Meds, and Eden, operate under different circumstances, but the regulatory environment for compounders remains active and worth monitoring before you commit to a plan.
What does a 503A pharmacy designation actually mean for a patient ordering compounded GLP-1s?
A 503A facility compounds medications for individual patients under a valid prescription and must meet USP standards for sterility and potency. It is not the same as a 503B outsourcing facility, which can produce larger batches. For patients, 503A means the medication is made to order, lot-tracked, and subject to state board oversight. It does not mean FDA-approved. Lot-to-door tracking, as offered by HealthRX through Manifest Pharmacy, adds an additional verification layer most 503A providers skip.
Which provider on this list makes the most sense if you have insurance and want a branded drug rather than a compounded one?
Hims & Hers and Ro Body are the clearest options. Hims & Hers now focuses on branded medications and, with insurance plus a manufacturer savings card, costs can reach as low as $0 to $25 per month. Ro has a dedicated prior-authorization team specifically for working through insurance on branded GLP-1s. PlushCare also works with insurance but offers less weight-loss-specific support than either of those two.
Sources
- FDA: Warning letters to compounding facilities and telehealth companies, 2026
- SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022 (tirzepatide weight-loss outcomes)
- STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021 (semaglutide weight-loss outcomes)
- LegitScript pharmacy certification database (publicly searchable)
- Novo Nordisk compounding settlement, March 9 2026, public press releases
- Lilly: LillyDirect orforglipron launch, publicly announced April 2026
